Hyperlipidemia-Type Non-Alcoholic Fatty Liver Disease (NAFLD)
Conditions
Interventions
The experimental group:Oral administration of Granules of Dizhu Huayu Decoction
The control group:Oral administration of polyene phosphatidylcholine capsules
Sponsors
The First Affiliated Hospital of Henan University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
22 Years to 68 Years
Inclusion criteria
Inclusion criteria: (1) Age: 18-70 years old, no gender restrictions; (2) Meet the diagnostic criteria for hyperlipidemia and non-alcoholic fatty liver disease (NAFLD); (3) Serum ALT/AST = 2 times the upper limit of normal; (4) Sign the informed consent form; (5) Have not taken other NAFLD treatment medications, or have discontinued other NAFLD treatment medications for more than 4 weeks.
Exclusion criteria
Exclusion criteria: Any of the following conditions will result in exclusion: (1) Dyslipidemia caused by medication for other diseases; (2) Patients with autoimmune hepatitis, chronic severe hepatitis, drug-induced liver injury, viral hepatitis, or genetic metabolic diseases; (3) Patients with depression, anxiety, or other mental health disorders; (4) Patients suffering from severe cardiovascular, cerebrovascular, hematopoietic, or renal system diseases; (5) Pregnant or breastfeeding patients; (6) Patients with known allergy to this prescription drug or with a history of allergic reactions; (7) Patients currently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| total cholesterol;triglyceride;high-density lipoprotein cholesterol ;low-density lipoprotein cholesterol;Liver CAP value; | — |
Secondary
| Measure | Time frame |
|---|---|
| alanine aminotransferase;aspartate aminotransferase;adiponectin;tumor necrosis factor-a;traditional Chinese medicine syndrome score;Body Mass Index value; | — |
Countries
China
Contacts
Public ContactLiang Haowei
The First Affiliated Hospital of Henan University of Chinese Medicine
Outcome results
None listed